REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 209 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $75,043 | +111904.5% | 736 | -0.7% | 0.00% | 0.0% |
Q1 2023 | $67 | +570.0% | 741 | +195.2% | 0.00% | – |
Q4 2022 | $10 | -99.9% | 251 | +2.4% | 0.00% | – |
Q3 2022 | $8,000 | -11.1% | 245 | -21.0% | 0.00% | – |
Q2 2022 | $9,000 | -98.4% | 310 | -98.2% | 0.00% | -100.0% |
Q1 2022 | $570,000 | +10.9% | 17,389 | -4.9% | 0.00% | 0.0% |
Q4 2021 | $514,000 | +192.0% | 18,278 | +945.1% | 0.00% | +300.0% |
Q3 2021 | $176,000 | -50.0% | 1,749 | -29.7% | 0.00% | -50.0% |
Q2 2021 | $352,000 | +21.0% | 2,488 | -14.7% | 0.00% | 0.0% |
Q1 2021 | $291,000 | +37.3% | 2,918 | +69.8% | 0.00% | +100.0% |
Q4 2020 | $212,000 | +100.0% | 1,718 | +58.6% | 0.00% | 0.0% |
Q3 2020 | $106,000 | -69.7% | 1,083 | -51.7% | 0.00% | -66.7% |
Q2 2020 | $350,000 | +136.5% | 2,242 | +119.2% | 0.00% | +50.0% |
Q1 2020 | $148,000 | -27.8% | 1,023 | +2.0% | 0.00% | 0.0% |
Q4 2019 | $205,000 | +78.3% | 1,003 | -29.9% | 0.00% | +100.0% |
Q3 2019 | $115,000 | +721.4% | 1,430 | +853.3% | 0.00% | – |
Q2 2019 | $14,000 | +7.7% | 150 | 0.0% | 0.00% | – |
Q1 2019 | $13,000 | – | 150 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |